Eisler Capital (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Eisler Capital (UK)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$33.5M	Buy	646,950 +309,257	+92%	+$14.5M	0.15%	129
2024 Q2	$14M	Sell	337,693 -17,711	-5%	-$792K	0.09%	208
2024 Q1	$19.3M	Buy	355,404 +199,487	+128%	+$10.2M	0.16%	139
2023 Q4	$8M	Buy	155,917 +138,272	+784%	+$7.26M	0.06%	236
2023 Q3	$1.02M	Buy	+17,645	New	+$1.08M	0.01%	375
2022 Q2	–	Sell	-600,000	Closed	-$43.8M	–	412
2022 Q1	$43.8M	Buy	+600,000	New	+$40.3M	0.74%	33

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eisler Capital (UK)'s BMY Position: Q3 2024 in Review

Eisler Capital (UK) reduced its Bristol-Myers Squibb (BMY) stake by 68% in Q3 2024, selling an estimated $1.11M and leaving 11,317 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Eisler Capital (UK) first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.45M in Q2 2024. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

Eisler Capital (UK) held 11,317 shares of Bristol-Myers Squibb worth $586K as of Q3 2024.
Eisler Capital (UK) sold 23,602 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.11M.
Bristol-Myers Squibb made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #522 holding.
Eisler Capital (UK) first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
Eisler Capital (UK)'s Bristol-Myers Squibb position peaked at $1.45M in Q2 2024.
2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.